Version 5.4
Mus musculus Gene: Men1
Summary
InnateDB Gene IDBG-135755.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Men1
Gene Name multiple endocrine neoplasia 1
Synonyms AW045611
Species Mus musculus
Ensembl Gene ENSMUSG00000024947
Encoded Proteins
IDBP-135757
multiple endocrine neoplasia 1
IDBP-135759
multiple endocrine neoplasia 1
IDBP-135761
multiple endocrine neoplasia 1
IDBP-253735
multiple endocrine neoplasia 1
IDBP-253737
multiple endocrine neoplasia 1
IDBP-253739
multiple endocrine neoplasia 1
IDBP-253741
multiple endocrine neoplasia 1
IDBP-253743
multiple endocrine neoplasia 1
IDBP-619863
multiple endocrine neoplasia 1
IDBP-619864
multiple endocrine neoplasia 1
IDBP-619865
multiple endocrine neoplasia 1
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary This gene does not have any Entrez summary - the following is the summary from its human ortholog ENSG00000133895:
This gene encodes menin, a putative tumor suppressor associated with a syndrome known as multiple endocrine neoplasia type 1. In vitro studies have shown menin is localized to the nucleus, possesses two functional nuclear localization signals, and inhibits transcriptional activation by JunD, however, the function of this protein is not known. Two messages have been detected on northern blots but the larger message has not been characterized. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2008]
Gene Information
Type Protein coding
Genomic Location Chromosome 19:6334979-6340891
Strand Forward strand
Band A
Transcripts
ENSMUST00000079327 ENSMUSP00000078306
ENSMUST00000056391 ENSMUSP00000058149
ENSMUST00000078137 ENSMUSP00000077272
ENSMUST00000113504 ENSMUSP00000109132
ENSMUST00000113503 ENSMUSP00000109131
ENSMUST00000113502 ENSMUSP00000109130
ENSMUST00000113501 ENSMUSP00000109129
ENSMUST00000113500 ENSMUSP00000109128
ENSMUST00000156154
ENSMUST00000166909 ENSMUSP00000133085
ENSMUST00000170132 ENSMUSP00000126655
ENSMUST00000170292 ENSMUSP00000128607
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 12 experimentally validated interaction(s) in this database.
They are also associated with 61 interaction(s) predicted by orthology.
Experimentally validated
Total 12 [view]
Protein-Protein 12 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 61 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0000400 four-way junction DNA binding
GO:0000403 Y-form DNA binding
GO:0003677 DNA binding
GO:0003682 chromatin binding
GO:0003690 double-stranded DNA binding
GO:0005515 protein binding
GO:0018024 histone-lysine N-methyltransferase activity
GO:0030674 protein binding, bridging
GO:0043565 sequence-specific DNA binding
GO:0044212 transcription regulatory region DNA binding
GO:0047485 protein N-terminus binding
GO:0070412 R-SMAD binding
Biological Process
GO:0000122 negative regulation of transcription from RNA polymerase II promoter
GO:0000165 MAPK cascade
GO:0001503 ossification
GO:0001776 leukocyte homeostasis
GO:0001933 negative regulation of protein phosphorylation
GO:0002051 osteoblast fate commitment
GO:0002076 osteoblast development
GO:0006338 chromatin remodeling
GO:0006351 transcription, DNA-templated
GO:0006974 cellular response to DNA damage stimulus
GO:0007050 cell cycle arrest
GO:0007420 brain development
GO:0008285 negative regulation of cell proliferation
GO:0009411 response to UV
GO:0010332 response to gamma radiation
GO:0016571 histone methylation
GO:0030097 hemopoiesis
GO:0030511 positive regulation of transforming growth factor beta receptor signaling pathway
GO:0031062 positive regulation of histone methylation
GO:0032092 positive regulation of protein binding
GO:0032925 regulation of activin receptor signaling pathway
GO:0034968 histone lysine methylation
GO:0043065 positive regulation of apoptotic process
GO:0043280 positive regulation of cysteine-type endopeptidase activity involved in apoptotic process
GO:0043433 negative regulation of sequence-specific DNA binding transcription factor activity
GO:0045597 positive regulation of cell differentiation
GO:0045668 negative regulation of osteoblast differentiation
GO:0045669 positive regulation of osteoblast differentiation
GO:0045736 negative regulation of cyclin-dependent protein serine/threonine kinase activity
GO:0045786 negative regulation of cell cycle
GO:0045892 negative regulation of transcription, DNA-templated
GO:0045893 positive regulation of transcription, DNA-templated
GO:0045944 positive regulation of transcription from RNA polymerase II promoter
GO:0046329 negative regulation of JNK cascade
GO:0046621 negative regulation of organ growth
GO:0048704 embryonic skeletal system morphogenesis
GO:0051781 positive regulation of cell division
GO:0051974 negative regulation of telomerase activity
GO:0060021 palate development
GO:0060135 maternal process involved in female pregnancy
Cellular Component
GO:0000785 chromatin
GO:0005634 nucleus
GO:0005737 cytoplasm
GO:0005829 cytosol
GO:0016363 nuclear matrix
GO:0032154 cleavage furrow
GO:0035097 histone methyltransferase complex
GO:0043234 protein complex
Orthologs
Species
Homo sapiens
Bos taurus
Gene ID
Gene Order
ENSG00000133895
View Gene Order
ENSBTAG00000002095
Not yet available
Pathways
NETPATH
REACTOME
REACT_217958
SMAD2/3 Phosphorylation Motif Mutants in Cancer pathway
REACT_189085
Disease pathway
REACT_214014
Signaling by Wnt pathway
REACT_233046
Signaling by WNT in cancer pathway
REACT_215068
Loss of Function of SMAD4 in Cancer pathway
REACT_213336
Signaling by TGF-beta Receptor Complex in Cancer pathway
REACT_224217
TGFBR1 LBD Mutants in Cancer pathway
REACT_204241
Loss of Function of TGFBR2 in Cancer pathway
REACT_219771
deactivation of the beta-catenin transactivating complex pathway
REACT_216539
formation of the beta-catenin:TCF transactivating complex pathway
REACT_262115
misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling pathway
REACT_241644
RNF mutants show enhanced WNT signaling and proliferation pathway
REACT_207044
TCF dependent signaling in response to WNT pathway
REACT_216792
SMAD2/3 MH2 Domain Mutants in Cancer pathway
REACT_224787
TGFBR2 Kinase Domain Mutants in Cancer pathway
REACT_233572
Gene Expression pathway
REACT_223317
Loss of Function of TGFBR1 in Cancer pathway
REACT_209370
TGFBR2 MSI Frameshift Mutants in Cancer pathway
REACT_202264
SMAD4 MH2 Domain Mutants in Cancer pathway
REACT_206529
Generic Transcription Pathway pathway
REACT_188257
Signal Transduction pathway
REACT_224802
TGFBR1 KD Mutants in Cancer pathway
REACT_212101
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer pathway
REACT_225428
Signaling by TGF-beta Receptor Complex pathway
REACT_226256
Loss of Function of SMAD2/3 in Cancer pathway
REACT_203903
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription pathway
REACT_241402
XAV939 inhibits tankyrase, stabilizing AXIN pathway
KEGG
INOH
PID NCI
Pathway Predictions based on Human Orthology Data
NETPATH
REACTOME
REACT_120734
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription pathway
REACT_12627
Generic Transcription Pathway pathway
REACT_169107
SMAD4 MH2 Domain Mutants in Cancer pathway
REACT_228096
misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling pathway
REACT_228331
Signaling by WNT in cancer pathway
REACT_169219
Loss of Function of SMAD4 in Cancer pathway
REACT_169398
Loss of Function of SMAD2/3 in Cancer pathway
REACT_169122
Signaling by TGF-beta Receptor Complex in Cancer pathway
REACT_11045
Signaling by Wnt pathway
REACT_200731
deactivation of the beta-catenin transactivating complex pathway
REACT_169192
TGFBR2 MSI Frameshift Mutants in Cancer pathway
REACT_111102
Signal Transduction pathway
REACT_121061
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer pathway
REACT_169165
SMAD2/3 MH2 Domain Mutants in Cancer pathway
REACT_169435
Loss of Function of TGFBR2 in Cancer pathway
REACT_169103
SMAD2/3 Phosphorylation Motif Mutants in Cancer pathway
REACT_200777
TCF dependent signaling in response to WNT pathway
REACT_169263
TGFBR1 KD Mutants in Cancer pathway
REACT_228188
RNF mutants show enhanced WNT signaling and proliferation pathway
REACT_169311
Loss of Function of TGFBR1 in Cancer pathway
REACT_200753
formation of the beta-catenin:TCF transactivating complex pathway
REACT_169445
TGFBR1 LBD Mutants in Cancer pathway
REACT_169440
TGFBR2 Kinase Domain Mutants in Cancer pathway
REACT_228279
XAV939 inhibits tankyrase, stabilizing AXIN pathway
REACT_71
Gene Expression pathway
REACT_116125
Disease pathway
REACT_6844
Signaling by TGF-beta Receptor Complex pathway
REACT_212636
Signaling by Wnt pathway
REACT_242703
Signaling by WNT in cancer pathway
REACT_227938
Generic Transcription Pathway pathway
REACT_221739
Loss of Function of TGFBR1 in Cancer pathway
REACT_217678
Signaling by TGF-beta Receptor Complex pathway
REACT_220609
SMAD2/3 MH2 Domain Mutants in Cancer pathway
REACT_217918
TCF dependent signaling in response to WNT pathway
REACT_207152
Loss of Function of SMAD4 in Cancer pathway
REACT_234280
misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling pathway
REACT_203419
deactivation of the beta-catenin transactivating complex pathway
REACT_209241
Loss of Function of TGFBR2 in Cancer pathway
REACT_226022
Gene Expression pathway
REACT_242720
XAV939 inhibits tankyrase, stabilizing AXIN pathway
REACT_211897
TGFBR2 Kinase Domain Mutants in Cancer pathway
REACT_214353
Signal Transduction pathway
REACT_211138
Signaling by TGF-beta Receptor Complex in Cancer pathway
REACT_223827
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer pathway
REACT_236591
RNF mutants show enhanced WNT signaling and proliferation pathway
REACT_207908
SMAD4 MH2 Domain Mutants in Cancer pathway
REACT_224116
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription pathway
REACT_207832
TGFBR2 MSI Frameshift Mutants in Cancer pathway
REACT_222355
formation of the beta-catenin:TCF transactivating complex pathway
REACT_216195
Loss of Function of SMAD2/3 in Cancer pathway
REACT_220643
TGFBR1 LBD Mutants in Cancer pathway
REACT_207087
Disease pathway
REACT_209664
SMAD2/3 Phosphorylation Motif Mutants in Cancer pathway
REACT_223905
TGFBR1 KD Mutants in Cancer pathway
KEGG
INOH
PID NCI
Cross-References
SwissProt O88559
TrEMBL
UniProt Splice Variant
Entrez Gene 17283
UniGene Mm.12917 Mm.453222
RefSeq NM_001168488 NM_001168489 NM_001168490 NM_008583
OMIM
CCDS CCDS29502 CCDS50366 CCDS50367
HPRD
IMGT
MGI ID MGI:1316736
MGI Symbol Men1
EMBL AB023401 AF016398 AF024513 AF072755 AF093756 AF109389 AF109390 AF130368 AK154371 AK170713 BC036287 CH466612
GenPept AAC26001 AAC78843 AAC79938 AAC79939 AAD37498 AAD38333 AAF01352 AAH36287 BAA74964 BAE32542 BAE41971 EDL33234 EDL33236
RNA Seq Atlas 17283

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca